Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Comparison of mesoporous silicon and non-ordered mesoporous silica materials as drug carriers for itraconazole
Päivi Kinnari, Ermei Mäkilä, Teemu Heikkilä, et al.
International Journal of Pharmaceutics (2011) Vol. 414, Iss. 1-2, pp. 148-156
Closed Access | Times Cited: 136

Showing 1-25 of 136 citing articles:

Emerging trends in the stabilization of amorphous drugs
Riikka Laitinen, Korbinian Löbmann, Clare J. Strachan, et al.
International Journal of Pharmaceutics (2012) Vol. 453, Iss. 1, pp. 65-79
Closed Access | Times Cited: 425
Mesoporous systems for poorly soluble drugs
Wujun Xu, Joakim Riikonen, Vesa‐Pekka Lehto
International Journal of Pharmaceutics (2012) Vol. 453, Iss. 1, pp. 181-197
Closed Access | Times Cited: 219
Tailoring Porous Silicon for Biomedical Applications: From Drug Delivery to Cancer Immunotherapy
Wei Li, Zehua Liu, Flavia Fontana, et al.
Advanced Materials (2018) Vol. 30, Iss. 24
Closed Access | Times Cited: 179
Mesoporous Silica Particles as Drug Delivery Systems—The State of the Art in Loading Methods and the Recent Progress in Analytical Techniques for Monitoring These Processes
Katarzyna Trzeciak, Agata Chotera, Irena Bąk-Sypień, et al.
Pharmaceutics (2021) Vol. 13, Iss. 7, pp. 950-950
Open Access | Times Cited: 117
Recent advances in mesoporous silica nanoparticle: synthesis, drug loading, release mechanisms, and diverse applications
Rabia Fatima, Pratima Katiyar, Kushwaha Kalpana
Frontiers in Nanotechnology (2025) Vol. 7
Open Access | Times Cited: 2
Porous Silicon Nanoparticles for Nanomedicine: Preparation and Biomedical Applications
Hélder A. Santos, Ermei Mäkilä, Anu J. Airaksinen, et al.
Nanomedicine (2014) Vol. 9, Iss. 4, pp. 535-554
Closed Access | Times Cited: 185
Mesoporous silica formulation strategies for drug dissolution enhancement: a review
Carol A. McCarthy, Robert J. Ahern, Rakesh Dontireddy, et al.
Expert Opinion on Drug Delivery (2015) Vol. 13, Iss. 1, pp. 93-108
Closed Access | Times Cited: 171
Diatom silica microparticles for sustained release and permeation enhancement following oral delivery of prednisone and mesalamine
Hongbo Zhang, Mohammad‐Ali Shahbazi, Ermei Mäkilä, et al.
Biomaterials (2013) Vol. 34, Iss. 36, pp. 9210-9219
Closed Access | Times Cited: 136
Surface chemistry of porous silicon and implications for drug encapsulation and delivery applications
Karyn L. Jarvis, Timothy J. Barnes, Clive A. Prestidge
Advances in Colloid and Interface Science (2012) Vol. 175, pp. 25-38
Closed Access | Times Cited: 123
Nanostructured porous Si-based nanoparticles for targeted drug delivery
Mohammad‐Ali Shahbazi, Barbara Herranz, Hélder A. Santos
Biomatter (2012) Vol. 2, Iss. 4, pp. 296-312
Open Access | Times Cited: 121
Lipophilicity and hydrophobicity considerations in bio-enabling oral formulations approaches – a PEARRL review
Felix Ditzinger, Daniel J. Price, Alexandra-Roxana Ilie, et al.
Journal of Pharmacy and Pharmacology (2018) Vol. 71, Iss. 4, pp. 464-482
Open Access | Times Cited: 121
Amine-modified hyaluronic acid-functionalized porous silicon nanoparticles for targeting breast cancer tumors
Patrick Almeida, Mohammad‐Ali Shahbazi, Ermei Mäkilä, et al.
Nanoscale (2014) Vol. 6, Iss. 17, pp. 10377-10387
Open Access | Times Cited: 106
Chitosan-modified porous silicon microparticles for enhanced permeability of insulin across intestinal cell monolayers
Neha Shrestha, Mohammad‐Ali Shahbazi, Francisca Araújo, et al.
Biomaterials (2014) Vol. 35, Iss. 25, pp. 7172-7179
Closed Access | Times Cited: 103
Self emulsifying drug delivery system for enhanced solubility and dissolution of glipizide
Anuj G. Agrawal, Ashok Kumar, Paraag Gide
Colloids and Surfaces B Biointerfaces (2014) Vol. 126, pp. 553-560
Closed Access | Times Cited: 98
Porous Silicon Nanodiscs for Targeted Drug Delivery
Hashim Alhmoud, Bahman Delalat, Roey Elnathan, et al.
Advanced Functional Materials (2014) Vol. 25, Iss. 7, pp. 1137-1145
Closed Access | Times Cited: 90
A new cocrystal and salts of itraconazole: Comparison of solid-state properties, stability and dissolution behavior
Anna Shevchenko, Luís M. Bimbo, Inna Miroshnyk, et al.
International Journal of Pharmaceutics (2012) Vol. 436, Iss. 1-2, pp. 403-409
Closed Access | Times Cited: 87
Microfluidic assembly of multistage porous silicon–lipid vesicles for controlled drug release
Bárbara Herranz‐Blanco, Laura R. Arriaga, Ermei Mäkilä, et al.
Lab on a Chip (2014) Vol. 14, Iss. 6, pp. 1083-1086
Open Access | Times Cited: 81
Effects of particle morphology, pore size and surface coating of mesoporous silica on Naproxen dissolution rate enhancement
Zhuo Guo, Xiaomeng Liu, Lei Ma, et al.
Colloids and Surfaces B Biointerfaces (2012) Vol. 101, pp. 228-235
Closed Access | Times Cited: 80
Tumour homing peptide-functionalized porous silicon nanovectors for cancer therapy
Päivi Kinnari, Maija Hyvönen, Ermei Mäkilä, et al.
Biomaterials (2013) Vol. 34, Iss. 36, pp. 9134-9141
Closed Access | Times Cited: 80
Nanostructured Porous Silicon‐Solid Lipid Nanocomposite: Towards Enhanced Cytocompatibility and Stability, Reduced Cellular Association, and Prolonged Drug Release
Dongfei Liu, Ermei Mäkilä, Hongbo Zhang, et al.
Advanced Functional Materials (2012) Vol. 23, Iss. 15, pp. 1893-1902
Open Access | Times Cited: 79
Inhibition of Influenza A Virus Infection in Vitro by Saliphenylhalamide-Loaded Porous Silicon Nanoparticles
Luís M. Bimbo, Oxana V. Denisova, Ermei Mäkilä, et al.
ACS Nano (2013) Vol. 7, Iss. 8, pp. 6884-6893
Closed Access | Times Cited: 78
Successfully tailoring the pore size of mesoporous silica nanoparticles: Exploitation of delivery systems for poorly water-soluble drugs
Lejiao Jia, Jingyi Shen, Zhenyu Li, et al.
International Journal of Pharmaceutics (2012) Vol. 439, Iss. 1-2, pp. 81-91
Closed Access | Times Cited: 77
Surface chemistry dependent immunostimulative potential of porous silicon nanoplatforms
Mohammad‐Ali Shahbazi, Tahía D. Fernández, Ermei Mäkilä, et al.
Biomaterials (2014) Vol. 35, Iss. 33, pp. 9224-9235
Closed Access | Times Cited: 76
Conductive vancomycin-loaded mesoporous silica polypyrrole-based scaffolds for bone regeneration
Nazanin Zanjanizadeh Ezazi, Mohammad‐Ali Shahbazi, Yu. V. Shatalin, et al.
International Journal of Pharmaceutics (2017) Vol. 536, Iss. 1, pp. 241-250
Open Access | Times Cited: 70
Activated carbon as a carrier for amorphous drug delivery: Effect of drug characteristics and carrier wettability
Nikhila Miriyala, Defang Ouyang, Yvonne Perrie, et al.
European Journal of Pharmaceutics and Biopharmaceutics (2017) Vol. 115, pp. 197-205
Open Access | Times Cited: 67
Page 1 - Next Page

Scroll to top